Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Wellgistics Health has acquired Tollo Health, a pharmacy business in the United States, for $20 million. Wellgistics Health acquisitions focus on pharmacy distribution and blockchain-enabled healthcare utilization technology, while Tollo Health operates in pharmacy-related services tied to patient delivery and credentialing workflows. The Tollo Health acquisition supports Wellgistics Health’s platform acquisition strategy by expanding pharmacy acquisition capabilities and integrating secure, biometric-enabled last-mile delivery and verification. The healthcare M&A is structured as a platform acquisition backed by private equity acquisition interests, with deal consideration referenced at $2 million, $6.5 million, $5 million, $4 billion, and $20 million across proposed terms.
Filed under
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026